TRICYCLIC SPACER SYSTEMS FOR NONLINEAR OPTICAL DEVICES
20210002270 ยท 2021-01-07
Inventors
Cpc classification
C07D403/04
CHEMISTRY; METALLURGY
International classification
C07D241/38
CHEMISTRY; METALLURGY
C07D403/04
CHEMISTRY; METALLURGY
Abstract
A compound for spacing nonlinear optical chromophores of the Formula I
##STR00001##
and the commercially acceptable salts, solvates and hydrates thereof, wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, W, X, Y, Z, Q.sup.1, Q.sup.2, Q.sup.4 and L have the definitions provided herein.
Claims
1. A compound for spacing nonlinear optical chromophores of the Formula I ##STR00017## or a commercially acceptable salt thereof; wherein R.sub.3 is a C.sub.6-C.sub.10 aryl, C.sub.6-C.sub.10 heteroaryl, 4-10 membered heterocyclic or a C.sub.6-C.sub.10 saturated cyclic group; 1 or 2 carbon atoms in the foregoing cyclic moieties are optionally substituted by an oxo (O) moiety; and the foregoing R.sup.3 groups are optionally substituted by 1 to 3 R.sup.5 groups; R.sub.1 and R.sub.2 are independently selected from the list of substituents provided in the definition of R.sub.3, (CH.sub.2).sub.t(C.sub.6-C.sub.10 aryl) or (CH.sub.2).sub.t(4-10 membered heterocyclic), t is an integer ranging from 0 to 5, and the foregoing R.sub.1 and R.sub.2 groups are optionally substituted by 1 to 3 R.sup.5 groups; R.sub.4 is independently selected from the list of substituents provided in the definition of R.sub.3, a chemical bond (), or hydrogen; each Q.sup.1, Q.sup.2, and Q.sup.4 is independently selected from hydrogen, halo, C.sub.1-C.sub.10 alkyl, C.sub.2-C.sub.10 alkenyl, C.sub.2-C.sub.10 alkynyl, nitro, trifluoromethyl, trifluoromethoxy, azido, OR.sup.5, NR.sup.6C(O)OR.sup.5, NR.sup.6SO.sub.2R.sup.5, SO.sub.2NR.sup.5R.sup.6, NR.sup.6C(O)R.sup.5, C(O)NR.sup.5R.sup.6, NR.sup.5R.sup.6, S(O).sub.jR.sup.7 wherein j is an integer ranging from 0 to 2, NR.sup.5(CR.sup.6R.sup.7).sub.tOR.sup.6, (CH.sub.2).sub.t(C.sub.6-C.sub.10 aryl), SO.sub.2(CH.sub.2).sub.t(C.sub.6-C.sub.10 aryl), S(CH.sub.2).sub.t(C.sub.6-C.sub.10 aryl), O(CH.sub.2).sub.t(C.sub.6-C.sub.10 aryl), (CH.sub.2).sub.t(4-10 membered heterocyclic), and (CR.sup.6R.sup.7).sub.mOR.sup.6, wherein m is an integer from 1 to 5 and t is an integer from 0 to 5; with the proviso that when R.sup.4 is hydrogen Q.sup.4 is not available; said alkyl group optionally contains 1 or 2 hetero moieties selected from O, S and N(R.sup.6) said aryl and heterocyclic Q groups are optionally fused to a C.sub.6-C.sub.10 aryl group, a C.sub.5-C.sub.8 saturated cyclic group, or a 4-10 membered heterocyclic group; 1 or 2 carbon atoms in the foregoing heterocyclic moieties are optionally substituted by an oxo (O) moiety; and the alkyl, aryl and heterocyclic moieties of the foregoing Q groups are optionally substituted by 1 to 3 substituents independently selected from nitro, trifluoromethyl, trifluoromethoxy, azido, NR.sup.6SO.sub.2R.sup.5, SO.sub.2NR.sup.5R.sup.6, NR.sup.6C(O)R.sup.5, C(O)NR.sup.5R.sup.6, NR.sup.5R.sup.6, (CR.sup.6R.sup.7).sub.mOR.sup.6 wherein m is an integer from 1 to 5, OR and the substituents listed in the definition of R.sup.5; each R.sup.5 is independently selected from H, C.sub.1-C.sub.10 alkyl, (CH.sub.2).sub.t(C.sub.6-C.sub.10 aryl), and (CH.sub.2).sub.t(4-10 membered heterocyclic), wherein t is an integer from 0 to 5; said alkyl group optionally includes 1 or 2 hetero moieties selected from O, S and N(R.sup.6) said aryl and heterocyclic R.sup.5 groups are optionally fused to a C.sub.6-C.sub.10 aryl group, a C.sub.5-C.sub.8 saturated cyclic group, or a 4-10 membered heterocyclic group; and the foregoing R.sup.5 substituents, except H, are optionally substituted by 1 to 3 substituents independently selected from nitro, trifluoromethyl, trifluoromethoxy, azido, NR.sup.6C(O)R.sup.7, C(O)NR.sup.6R.sup.7, NR.sup.6R.sup.7, hydroxy, C.sub.1-C.sub.6 alkyl, and C.sub.1-C.sub.6 alkoxy; each R.sup.6 and R.sup.7 is independently H or C.sub.1-C.sub.6 alkyl; X, Y and Z are each independently selected from C (carbon), O (oxygen), N (nitrogen), and S (sulfur), and are included within R.sup.3; X, Y, and Z are immediately adjacent to one another; W is any non-hydrogen atom in R.sup.3 that is not X, Y, or Z; and L is a labile group or a nonlinear optical chromophore; with the proviso that when the compound of Formula I has the structure: ##STR00018## wherein L represents a labile group selected from the group consisting of hydroxyl groups, alkoxy groups, nitro groups, amines and halogens, and wherein Q.sup.1 and Q.sup.2 each represent a butoxy group; Q.sup.4 is not a methoxy group.
2. The compound of claim 1 wherein R.sup.1 and R.sup.2 are [1,3,4]thiadiazol-2-yl; R3 is indole; R4 is a single chemical bond; and Q.sup.1, Q.sup.2, and Q.sup.4 are methoxy.
3. The compound of claim 2 wherein X and Y are carbon, Z is nitrogen and L is amine.
3. A compound according to claim 1 wherein the compound of Formula I is selected from the group consisting of: ##STR00019## ##STR00020##
Description
BRIEF DESCRIPTION OF THE SEVERAL VIEWS OF THE DRAWINGS
[0040]
[0041]
[0042]
[0043]
[0044]
[0045]
[0046]
[0047]
[0048]
[0049]
[0050]
[0051]
[0052]
[0053]
DETAILED DESCRIPTION OF THE INVENTION
[0054] The compounds of Formula I are useful as agents for spacing nonlinear optical chromophores to prevent the chromophores from aggregating. Many useful NLO chromophores are known to those of ordinary skill in the art. While any NLO chromophore that provides the desired NLO effect and is compatible with the synthetic methods used to form the NLO spacer/chromophore may be used in the present invention, preferred NLO chromophores include an electron donating group and an electron withdrawing group.
[0055]
[0056] Essential to all subject systems of this Invention is the spacer system shown in 1B individually and multiply in 1C. Shown in 1D is the essential component on a chromophore substituted with optional Q-Groups. Shown in 1E, 1F, 1G and 1H are Q-Groups that are substituted. All systems illustrated as 1B, 1C, 1D, 1E, 1F, 1G and 1H lie within the scope of this Invention for Level 1 applications.
[0057] The various cyclic moieties of the spacer R.sup.1, R.sup.2, R.sup.3, and R.sup.4 may incorporate additional functional groups Q that add thermal stability to the spacer/chromophore system and also allow the spacer to serve as a polymeric monomer capable of being inserted into any of a number of polymer systems including polyamides, polyimides, polyesters, etc.
[0058] Nonlimiting examples of Q groups capable of providing polymerizable functionality to the spacer are provided in
[0059] A nonlimiting list of potential Q groups are provide in
[0060]
[0061] The compounds of Formula I may be prepared according to the following reaction schemes and discussions. The reaction schemes provide specific non-limiting examples of the manufacture of tricyclic spacer systems of the present invention. Each scheme demonstrates the structure common to all spacer systems of the present invention which is a central or primary cyclic structure, R.sup.3, having three atoms X, Y, and Z that are directly bonded to one another and where secondary cyclic moieties R.sup.1 and R.sup.2 are bound to atoms X and Z respectively.
##STR00005##
[0062] With reference to scheme 1 above, a compound of Formula I may be prepared by treating a 1-phenyl-ethanone substituted by a Q group (Q.sup.1) with a benzaldehyde substituted with Q.sup.3 to provide a 1,3-diphenyl-propenone where both phenyl groups are substituted. A second 1-phenyl-ethanone with Q4 substitution is reacted with the 1,3-diphenyl-propenone to produce the 2, 4, 6 triphenyl substituted pyranyl intermediate. The pyranyl intermediate is converted to a 2-Nitro-[1,1;3,1]terphenyl with phenyl substitution at the 5 position of the central ring. Additional chemistry may be performed on the nitro functional group to provide any number of labile functional groups that will be reactive with desired binding sites on a nonlinear optical chromophore.
[0063]
[0064] An alternative tricyclic spacer system is depicted in Scheme 2 wherein the central R.sup.3 cyclic moiety is an indole and R.sup.1 and R.sup.2 are both phenyl groups having methoxy Q groups. R.sup.4 is a chemical bond and Q.sup.4 is methoxy.
##STR00006## ##STR00007##
[0065] The present invention is illustrated by the following Examples. It will be understood, however, that the invention is not limited by the specific details of the following Examples.
Example 1
[0066] Preparation 4-Phenyl-m-Terphenyl Functionality into a Novel Chromophore (PT) (wherein A=NO2) with a 1-Amino-4-Phenyl-m-Terphenyl Key Intermediate.
##STR00008## ##STR00009##
Example 2
[0067] Preparation of 1,3-Bis-(4-methoxy-biphenyl-4-yl)-5-(4-methoxy-phenyl)-1H-indole Spacer with Attached Chromophore (PT) wherein A=NO.sub.2.
##STR00010## ##STR00011## ##STR00012##
Example 3
[0068] Specific Nonlimiting Conventional Synthetic Scheme for the Production of a Spacer system wherein the R.sub.3 Ring System is the Heterocyclic Indole Nucleus with a 5-Methoxy Substituent and wherein the R.sub.1 and R.sub.2 are Respectively the Hereocyclic 2-(1,3,4-Thiadiazole) Nucleus with a 5-Methoxy Substituent and a 4-Anisyl Substituents.
##STR00013## ##STR00014##
Example 4
[0069] Specific Nonlimiting Conventional Synthetic Scheme for the Production of a Spacer system wherein the R.sub.3 Ring System is the Heterocyclic Indole Nucleus with a 5-Methoxy Substituent and wherein the R.sub.1 and R.sub.2 are the Hereocyclic 2-(1,3,4-Thiadiazole) Nuclei.
##STR00015## ##STR00016##
[0070] While the preferred embodiment of the invention has been illustrated and described, it will be appreciated that various changes can be made therein without departing from the spirit and scope of the invention.